Physician Resources

NAFTnet

The North American Fetal Therapy Network provides information about fetal surgeries and complex care of disorders of the fetus. Visit NAFTNet for research, publications and descriptions.

Visit NaftNet

The Society of Obstetricians and Gynaecologists of Canada

The following SOGC (The Society of Obstetricians and Gynaecologists of Canada) national clinical guidelines in ob/gyn and related fields are available free of charge to health care practitioners and the public.

Visit SOGC

Clinical Practice Guidelines

The following SOGC national clinical guidelines in ob/gyn and related fields are available free of charge to health care practitioners and the public.


Contraception

280 Emergency Contraception – Replaces No. 131, August 2003
published September 2012
219 Missed Hormonal Contraceptives: New Recommendations Committee Opinion
published November 2008
205 Statement on Generic Oral Contraceptives
published March 2008
195 Canadian Consensus Guideline on Continuous and Extended Hormonal Contraception, 2007
published July 2007
174 Canadian Contraception Consensus – update on depot medroxyprogesterone acetate (DPMA) – Replaces #94 (Aug 2000), #21 (July/Aug 1993)
published April 2006
143 Canadian Contraception Consensus (Part 3 of 3) – Replaces #131(Aug 2003) and #49 (Sept 1996)
published April 2004
143 Canadian Contraception Consensus (Part 2 of 3) – Replaces #131(Aug 2003) and #49 (Sept 1996)
published March 2004
143 Canadian Contraception Consensus (Part 1 of 3) – Replaces #131(Aug 2003) and #49 (Sept 1996)
published February 2004

Diagnostic Imaging

260 Ultrasound in Twin Pregnancies
published June 2011
257 Ultrasonographic Cervical Length Assessment in Predicting Preterm Birth in Singleton Pregnancies
published May 2011
223 Content of a Complete Routine Second Trimester Obstetrical Ultrasound Examination and Report – Replaces #103 (May 2001)
published March 2009
192 Fetal Sex Determination and Disclosure Policy Statement
published April 2007
191 Non-Medical Use of Fetal Ultrasound Committee Opinion
published April 2007
162 Fetal Soft Markers in Obstetric Ultrasound
published June 2005
161 Ultrasound Evaluation of First Trimester Pregnancy Complications
published June 2005
160 Obstetric Ultrasound Biological Effects and Safety
published June 2005
135 The Use of First Trimester Ultrasound – endorsed by DI Committee Dec 2008
published October 2003
104 Guidelines for Ultrasound in Labour and Delivery Committee Opinion – endorsed by DI Committee Dec 2008
published May 2001
102 Ultrasound Cervical Assessment in Predicting Preterm Birth
published May 2001

Genetics

297 Investigation and Management of Non-immune Fetal Hydrops
published October 2013
287 Detection of Down Syndrome, Trisomy 18, and Trisomy 13 Using Cell-Free DNA in Maternal Plasma
published February 2013
277 Counselling Considerations for Prenatal Genetic Screening Committee Opinion
published May 2012
277 Counselling Considerations for Prenatal Genetic Screening Committee Opinion
published May 2012
271 Delayed Child-Bearing Committee Opinion
published January 2012
270 Use of Array Genomic Hybridization Technology in Prenatal Diagnosis in Canada Technical Update – Replaces #154 (January 2005)
published December 2011
267 Fetal and Perinatal Autopsy in Prenatally Diagnosed Fetal Abnormalities With Normal Karyotype
published October 2011
265 Use of a DNA Method, QF-PCR, in the Prenatal Diagnosis of Fetal Aneuploidies
published September 2011
262 Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies – Replaces #187 (February 2007)
published July 2011
261 Prenatal Screening for Fetal Aneuploidy in Singleton Pregnancies (Replaces #187 (February 2007))
published July 2011
253 Genetic Considerations for a Woman’s Pre-conception Evaluation Committee Opinion
published January 2011
234 Evaluation of Prenatally Diagnosed Structural Congenital Anomalies Committee Opinion
published September 2009
232 Preimplantation Genetic Testing Technical Update
published August 2009
218 Carrier Screening for Thalassemia and Hemoglobinopathies in Canada
published October 2008
217 Obstetrical Complications Associated With Abnormal Maternal Serum Markers Analytes Technical Update
published October 2008
216 Fragile X Testing in Obstetrics and Gynaecology in Canada Committee Opinion
published September 2008
210 New Molecular Techniques for the Prenatal Detection of Chromosomal Aneuploidy Technical Update
published July 2008
200 Teratogenicity Associated With Pre-Existing and Gestational Diabetes
published November 2007
199 Principles of Human Teratology: Drug, Chemical, and Infectious Exposure
published November 2007
194 Mid-Trimester Amniocentesis Fetal Loss Rate Committee Opinion
published July 2007
177 Carrier Screening for Genetic Disorders in Individuals of Ashkenazi Jewish Descent
published April 2006
173 Pregnancy Outcomes After Assisted Reproductive Technology
published March 2006
168 Amended Canadian Guideline for Prenatal Diagnosis (2005) Change to 2005-Techniques for Prenatal Diagnosis
published November 2005
167 Present Role of Stem Cells for Fetal Genetic Therapy Committee Opinion
published November 2005
162 Fetal Soft Markers in Obstetric Ultrasound
published June 2005
153 Cell-Free Fetal DNA in Maternal Circulation and its Future Uses in Obstetrics Technical Update
published January 2005
133 Prevention of RH Alloimmunization
published September 2003
123 Amniocentesis and Women with Hepatitis B, Hepatitis C, or Human Immunodeficiency Virus
published February 2003
118 Cystic Fibrosis Carrier Testing in Pregnancy in Canada Committee Opinion
published August 2002
105 Canadian Guidelines for Prenatal Diagnosis (Part 1 – Genetic Indications for Prenatal Diagnosis)
published June 2001

Guideline

159 Postural Health in Women: The Role of Physiotherapy
published May 2005

Gynaecology

300 Female Genital Cosmetic Surgery
published December 2013
299 Clinical Practice Guideline: Female Genital Cutting
published October 2013
238 Supracervical Hysterectomy
published January 2010
237 Mifepristone Policy Statement (Replaces #124 (Mar 2003))
published December 2009
229 The role of obstetrician-gynaecologists in Canada – Policy Statement (Replaces #42 (Nov 1995))
published July 2009
184 Induced Abortion Guidelines
published November 2006
176 Pelvic Examinations by Medical Trainees
published April 2006

Infectious Disease

298 The Prevention of Early-Onset Neonatal Group B Streptococcal Disease (replaces #149, Sept. 2004)
published October 2013
285 Toxoplasmosis in Pregnancy: Prevention, Screening, and Treatment
published January 2013
278 Canadian HIV Pregnancy Planning Guidelines
published June 2012
276 Management of Group B Streptococcal Bacteriuria in Pregnancy
published May 2012
274 Management of Varicella Infection (Chickenpox) in Pregnancy
published March 2012
247 Antibiotic Prophylaxis in Obstetric Procedures
published September 2010
240 Cytomegalovirus Infection in Pregnancy
published April 2010
236 Immunization in pregnancy (Replaces #220 (Dec 2008))
published November 2009
233 Antibiotic Therapy in Preterm Premature Rupture of the Membranes
published September 2009
225 Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS)
published April 2009
211 Screening and management of Bacterial Vaginosis in pregnancy (Replaces #14 (Mar 1997))
published August 2008
208 Guidelines for the management of Herpes Simplex virus in pregnancy (Replaces #2 (Aug 1992))
published June 2008
196 Canadian Consensus Guidelines on Human Papillomavirus (Replaces #69 (Dec 1997))
published August 2007
185 HIV Screening in Pregnancy (Replaces #62 (June 1997))
published December 2006
119 Parvovirus B19 Infection in Pregnancy
published September 2002
101 Mode of Delivery for Pregnant Women Infected by the Human Immunodeficiency Virus
published April 2001
96 The Reproductive Care of Women Living with Hepatitis C Infection
published October 2000

Maternal Fetal Medicine

297 Investigation and Management of Non-immune Fetal Hydrops
published October 2013
296 Induction of Labour (replaces No. 107, Aug. 2001)
published September 2013
295 Intrauterine Growth Restriction: Screening, Diagnosis, and Management
published August 2013
288 Cancer Chemotherapy and Pregnancy
published March 2013
282 Rural Maternity Care – Position Paper (Replaces #72, April 1998)
published October 2012
281 Classification of Caesarean Sections in Canada: The Modified Robson Criteria
published October 2012
258 Magnesium Sulphate for Fetal Neuroprotection
published May 2011
256 Substance Use in Pregnancy
published April 2011
245 Alcohol Use and Pregnancy Consensus Clinical Guidelines
published August 2010
239 Obesity in Pregnancy
published February 2010
231 Guidelines for the management of Vasa Praevia
published August 2009
226 Vaginal Delivery of Breech Presentation
published June 2009
224 Management of Meconium at Birth – Technical Update
published April 2009
209 Guideline for the Management of Postoperative Nausea and Vomiting
published July 2008
202 The use of progesterone for prevention of preterm birth – Technical Update
published January 2008
197 Fetal health Surveillance: antepartum and intrapartum Consensus Guideline (Replaces #130 (July 2003), #90 (June 2000), #112 (Mar 2002), #112 (April 2002))
published September 2007
189 Diagnosis and Management of Placenta Previa
published March 2007
178 Stillbirth and Bereavement: Guidelines for Stillbirth Investigation
published June 2006
156 Umbilical Cord Blood Banking: Implications for Perinatal Care Providers
published March 2005
133 Prevention of RH Alloimmunization
published September 2003
122 Antenatal Corticosteroid Therapy for Fetal Maturation – Committee Opinion (Replaces # 53 (December 1995))
published January 2003
121 Screening for Gestational Diabetes (Replaces # 1 (June 1992))
published November 2002
119 Parvovirus B19 Infection in Pregnancy
published September 2002
118 Cystic Fibrosis Carrier Testing in Pregnancy in Canada Committee Opinion
published August 2002
95 Prevention & Treatment of Venous Thromboembolism (VTE) in Obstetrics
published September 2000
93 Management of Twin Pregnancies (Part 2)
published August 2000
91 Management of Twin Pregnancies (Part 1)
published July 2000

Obstetrics

296 Induction of Labour (replaces No. 107, Aug. 2001)
published September 2013
295 Intrauterine Growth Restriction: Screening, Diagnosis, and Management
published August 2013
288 Cancer Chemotherapy and Pregnancy
published March 2013
286 Surgical Safety Checklist in Obstetrics and Gynaecology
published January 2013
282 Rural Maternity Care – Position Paper (Replaces #72, April 1998)
published October 2012
263 Maternity Leave in Normal Pregnancy – Policy Statement
published August 2011
236 Immunization in pregnancy (Replaces #220 (Dec 2008))
published November 2009
235 Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage (Replaces #88 (April 2000))
published October 2009
229 The role of obstetrician-gynaecologists in Canada – Policy Statement (Replaces #42 (Nov 1995))
published July 2009
227 Midwifery – Policy Statement (Replaces #126 (Mar 2003))
published July 2009
221 Joint Policy Statement on Normal Childbirth – Policy Statement
published December 2008
214 Guidelines for the management of pregnancy at 41+0 to 42+0 weeks (Replaces #15 (Mar 1997))
published September 2008
209 Guideline for the Management of Postoperative Nausea and Vomiting
published July 2008
206 Diagnosis, evaluation and management of the hypertensive disorders of pregnancy
published March 2008
204 Statement on Wait Times in Obstetrics and Gynaecology – Policy Statement
published March 2008
203 Rubella in Pregnancy
published February 2008
198 Statement on gender selection – Policy Statement (Replaces #32 (Dec 1994))
published November 2007
197 Fetal health Surveillance: antepartum and intrapartum Consensus Guideline (Replaces #130 (July 2003), #90 (June 2000), #112 (Mar 2002), #112 (April 2002))
published September 2007
190 Pospartum Maternal and Newborn Discharge – Policy Statement (Replaces #56 (Oct 1996))
published April 2007
165 Maternal Transport Policy – Policy Statement (Replaces #16 (Dec 1992))
published October 2005
163 Gynaecological and Obstetric Management of Women With Inherited Bleeding Disorders
published July 2005
155 Guidelines for Vaginal Birth After Previous Caesarean Birth (Replaces #147 (July 2004))
published February 2005
152 FIGO/ICM Global Initiative to Prevent Post-Partum Hemorrhage
published December 2004
148 Guidelines for Operative Vaginal Birth (Replaces #17 (Dec 1995))
published August 2004
136 Management of the Third Stage of Labour to Prevent Postpartum Hemorrhage
published November 2003
129 Exercise in Pregnancy and the Postpartum Period
published June 2003
126 Midwifery – Policy Statement (Replaced by #227 (July 2009) Replaces # 66 (Sept 1997))
published March 2003
120 The Management of Nausea & Vomiting of Pregnancy (Replaces # 12 (Nov 1995), #14 (Nov 1995))
published October 2002
115 Hemorrhagic Shock
published June 2002
114 Gestational Trophoblastic Disease
published May 2002
113 Number of Births to Maintain Competence – Policy Statement (Replaces #58 (Nov 1996))
published April 2002
89 Attendance at Labour & Delivery – Guidelines for Obstetrical Care – Policy Statement (Replaces #38 (Aug 1996))
published May 2000

Reproductive Endocrinology and Infertility

269 Advanced Reproductive Age and Fertility
published November 2011
241 Elective Single Embryo Transfer Following In Vitro Fertilization
published April 2010
182 Guidelines for the Number of Embryos to Transfer Following in Vitro Fertilization
published September 2006
173 Pregnancy Outcomes After Assisted Reproductive Technology
published March 2006

Social Sexual Issues

299 Clinical Practice Guideline: Female Genital Cutting
published October 2013
279 Female Sexual Health
published August 2012
272 Policy Statement: Female Genital Cutting/Mutilation
published February 2012
266 The Presence of a Third Party During Breast and Pelvic Examinations – Policy Statement (Replaces #125 (March 2003))
published September 2011
157 Intimate Partner Violence Consensus Statement
published April 2005
87 Lesbian Health Guidelines – Policy Statement
published March 2000

Special Pregnancy Program

Referrals »

Fetal Medicine: 416-586-4800 x 7756
Fax: 416-586-3216

Maternal Medicine: 416-586-4800 x 7000
Fax: 416-586-5109

Main clinic hours: Monday to Friday, 8am to 4pm

Prenatal Diagnosis & Medical Genetics

Referrals »

phone: 416-586-4800 x 4523
fax numbers:
416-586-4723 or 416-586-8384

Perinatal Mental Health

Referrals »

Phone: 416-586-4800 x 8325
Fax: 416-586-8596